## CPRT: Copart, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.8% below STRENGTH zone (3.0-6.0%); PEG 2.22 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($37.07)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Copart, Inc. $CPRT Stock Holdings Increased by State Street Corp**
- Source: MarketBeat | 20251211T114941 | Neutral | Relevance: 98%
-  State Street Corp increased its holdings in Copart, Inc. (NASDAQ:CPRT) by 3.3% during the 2nd quarter, now owning 36,406,503 shares worth approximately $1.78 billion. Several other institutional investors also adjusted their positions in CPRT. The company recently reported Q3 earnings, beating analyst estimates, although revenue was slightly below expectations.

**2. Marshall Wace LLP Decreases Stock Position in Copart, Inc. $CPRT**
- Source: MarketBeat | 20251209T121415 | Neutral | Relevance: 98%
-  Marshall Wace LLP significantly reduced its stake in Copart, Inc. (NASDAQ:CPRT) by 55.2% in the second quarter, selling over 621,000 shares. This move leaves the fund with 504,296 shares worth approximately $24.75 million. Despite this decrease, several other institutional investors have increased their positions in Copart, and analysts hold a consensus "Hold" rating with an average target price of $47.60.

**3. Harley Cherylyn LeBon At Copart Exercises Options Worth $0**
- Source: Benzinga | 20251210T150733 | Neutral | Relevance: 98%
- Harley Cherylyn LeBon, a Board Member at Copart (NASDAQ: CPRT), exercised stock options for 0 shares, with an exercise price of $0.0 per share. This transaction, highlighted on December 9th and disclosed in an SEC filing, brings the total value of LeBon's 0 shares to $0. The article also provides a financial overview of Copart, including its revenue growth, profitability, debt management, and valuation metrics.

**4. STEVEN COHAN Decides To Exercise Options At Copart Worth $0**
- Source: Benzinga | 20251210T150752 | Neutral | Relevance: 98%
-  STEVEN COHAN, a Director at Copart (NASDAQ: CPRT), disclosed an insider transaction on December 9, reporting the exercise of stock options for 0 shares. The exercise price was $0.0 per share, valuing this specific transaction at $0. Copart, an online salvage vehicle auction operator, shows positive revenue trends and strong gross margins, but its EPS lags behind industry averages.

**5. Copart Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains**
- Source: 富途牛牛 | 20251211T200752 | Neutral | Relevance: 97%
-  Copart Inc. (CPRT) stock underperformed its competitors on Wednesday, despite daily gains, with a 1.14% drop. The article also briefly mentions Unity Software's (U.US) fourth-quarter earnings, where revenue increased 35% year-over-year to $609 million, exceeding estimates, though the company reported a quarterly loss of 66 cents per share.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-24 | JP Morgan | $45 | $50 | -10% |
| 2025-11-21 | Barclays | $33 | $32 | +3% |
| 2025-11-21 | Baird | $52 | $55 | -5% |
| 2025-11-12 | Barclays | $32 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-24 | JP Morgan | main | Neutral |
| 2025-11-21 | Barclays | main | Underweight |
| 2025-11-21 | Baird | main | Outperform |
| 2025-11-12 | Barclays | init | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 13 ($1.50M) |
| Sells | 2 ($5.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.3% (+2.4%)
- Blackrock Inc.: 6.5% (-2.4%)
- Principal Financial : 4.2% (+3.2%)
- State Street Corpora: 3.8% (+1.8%)
- JPMORGAN CHASE & CO: 2.7% (+86.7%)

### Key Risks

1. Insider selling cluster: $5.1M in recent transactions.
2. Long-term trend broken: trading 21.7% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.22 elevated, pricing in significant growth expectations. Forward P/E 21.5x stretched relative to 10% growth. Quality metrics strong (ROA 11%, margin 34%). Balance sheet: strong liquidity (7.9x), low leverage (D/E 0.10). Analyst sentiment negative (2 target cuts vs 1 raises). Insider selling cluster ($5.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.5B |
| Beta | 1.12 |
| 52W Range | $38.18 - $63.85 |
| Short Interest | 3.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.22 |
| Forward P/E | 21.5 |
| Current P/E | 23.6 |
| YoY Growth | 9.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -2.6% to -0.8% (+1.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.8pp (needs >3.0% for momentum thesis). Below SMA200 (0.78x), long-term trend not supportive.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.75% (CS: 29) | Neutral |
| RSI_14 | 34.4 | Neutral |
| MACD Histogram | 0.09 | Bullish |
| vs SMA20 | 0.975x | Below |
| vs SMA50 | 0.921x | Below |
| vs SMA200 | 0.783x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $38.69
- **Stop Loss:** $37.07 (4.2% risk)
- **Target:** $40.31 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 851
- **Position Value:** $32,925.19
- **Portfolio %:** 32.93%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-19 (Est: $0.39)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.39 | $0.41 | +5.1% |
| 2025Q3 | $0.36 | $0.41 | +13.3% |
| 2025Q2 | $0.42 | $0.42 | +0.8% |
| 2025Q1 | $0.37 | $0.40 | +7.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*